Cybrdi, Inc. Share Price

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-50.91%

30/10/17	Xi’an Alena Biotechnology Co., Ltd completed the acquisition of 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc..	CI
18/07/17	Xi’an Alena Biotechnology Co., Ltd entered into a share transfer agreement to acquire 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc. for CNY 25.6 million.	CI

Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Companyâ€™s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.

Employees

Sector

Biotechnology & Medical Research

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
CYDI Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	2.52M 2.24M 2.08M 1.89M 3.57M 240M 3.63M 25M 9.8M 125M 9.48M 9.27M 399M	P/E 2012	-1.82x	P/E 2013	-2.85x
Enterprise Value	6.51M 5.79M 5.37M 4.88M 9.22M 618M 9.36M 64.52M 25.3M 323M 24.45M 23.93M 1.03B	EV / Sales 2012	3.25x	EV / Sales 2013	9.67x
Free-Float	29.19%	Yield 2012 *	-	Yield 2013	-

Manager	Title	Age	Since
Yan Biao Bai CEO	Chief Executive Officer	63	31/12/2002
Yong Hong Ren COO	Chief Operating Officer	-	18/08/2011

Director	Title	Age	Since
Yan Biao Bai CHM	Chairman	63	31/12/2002
Yong Hong Ren BRD	Director/Board Member	-	18/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYBRDI, INC.	-.--%	-.--%	-	-	325K
WUXI APPTEC CO., LTD.	-6.60%	-8.56%	+49.38%	+63.51%	65B
LONZA GROUP AG	+0.03%	+5.56%	+9.10%	+69.05%	51.2B
ARGENX SE	-4.09%	-0.11%	+2.22%	+53.15%	51.19B
IQVIA HOLDINGS INC.	-1.53%	+2.70%	+30.48%	+34.12%	43.93B
BEONE MEDICINES AG	-1.34%	+4.12%	+16.64%	+115.13%	41.96B
REVOLUTION MEDICINES, INC.	-5.97%	-6.22%	+228.95%	+454.22%	38.14B
CELLTRION, INC.	+6.53%	+8.02%	+16.40%	+53.41%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	-3.70%	25.2B
GENMAB A/S	-1.07%	+2.33%	+19.43%	+9.98%	22.5B
Average	-1.49%	-0.32%	+45.52%	+94.32%	37.24B
Weighted average by Cap.	-2.20%	-0.50%	+44.25%	+96.53%

	2012	2013
Net sales	783K 696K 645K 587K 1.11M 74.33M 1.13M 7.76M 3.04M 38.79M 2.94M 2.88M 124M	574K 510K 473K 430K 812K 54.5M 825K 5.69M 2.23M 28.44M 2.16M 2.11M 90.67M
Net income	-530K -471K -436K -397K -749K -50.28M -761K -5.25M -2.06M -26.24M -1.99M -1.95M -83.65M	-548K -487K -452K -411K -776K -52.04M -788K -5.43M -2.13M -27.16M -2.06M -2.01M -86.58M
Net Debt	1.58M 1.41M 1.3M 1.19M 2.24M 150M 2.28M 15.68M 6.15M 78.41M 5.94M 5.82M 250M	3.99M 3.55M 3.29M 2.99M 5.64M 379M 5.73M 39.51M 15.49M 198M 14.97M 14.66M 630M

Cybrdi, Inc. Share Price

Stocks

CYDI

US23254K1007

Biotechnology & Medical Research

Valuation: Cybrdi, Inc.

Latest news: Cybrdi, Inc.

Managers and Directors: Cybrdi, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile